USP 795 Archives - American College of Apothecaries

2025 American College of Apothecaries Conference & Expo

Taisha Cunningham2025-04-28T12:26:12-05:00April 28th, 2025|Categories: ACA Fellows Benefit, Administration/Management, Community Pharmacy, Compliance, compounding, Continuing Education, DEA, Ethics, FDA, Fellows and Members, Fellows Benefit, Member Benefits, networking, News Release, Pain Management, Patient Care, Patient Safety, Personal Development, Pharmacists, Pharmacy Law, Pharmacy Practice, Pharmacy Technicians, Preceptor/Mentor Training, Professional Development, Professional Growth, Public/Community Health, Regulatory Issues, Revenue, Risk Management, Sports Medicine, Telemedicine / Telepharmacy, USP 795, USP 797, USP 800, Veterinary Compounding, Webinar|Tags: ACA Fellows, ACA members, Healthcare Professionals, news, Pharmacists, Pharmacy Technicians, Student Pharmacists|

It’s time to pack your bags and polish your business cards — the 2025 ACA Annual Conference & Expo is where independent pharmacy meets unforgettable opportunity!

Memphis, TN | September 25–27, 2025

Join us at the legendary Peabody Hotel for the 2025 ACA Annual Conference & Expo — where independent pharmacy professionals come together to connect, learn, and grow.

Your registration includes:

• Continuing Education credit (except guest registration)

• Thursday Night Welcome Reception & Dinner

• All conference meals

• Full access to the exhibition hall

This is your chance to network with pharmacy leaders, discover the latest trends, and showcase your brand in a dynamic, in-person setting. With educational sessions, social events, and all meals included, this is more than a conference — it’s where pharmacy takes care of business!

Speakers Include:

Philip Cowley, PharmD
Kathy Campbell, PharmD
Jessica Beal, PharmD
Jennifer Adams, PharmD, EdD, FAPhA, FNAP
Sue Paul, RPh
L. Michelle Woosley, PharmD, MBA, CMAP

Reserve your spot today and be part of something meaningful!

Register Now

Reservations

The Peabody Memphis – The “South’s Grand Hotel”

The Peabody Memphis is legendary for its charm, elegance, gracious hospitality, and rich history. This Memphis icon, opened in 1869, is listed on the National Register of Historic Places and is world-famous for its five resident Mallard ducks, who march daily through the lobby at 11am and 5pm.

Nestled in the heart of downtown, this AAA Four-Diamond hotel offers a one-of-a-kind experience just blocks from Beale Street, the Memphis Rock ‘n Soul Museum, Fed-Ex Forum, Sun Studio, and the Orpheum Theatre. The Peabody Memphis offers two Restaurants, two Bars, Spa, and a Deli with ice cream and desserts.

THE PEABODY MEMPHIS
149 Union Avenue, Memphis TN 38103

Group Rate: $249 plus taxes and fees
Room Block Deadline: Monday, August 25, 2025, at 5:00 pm CDT

To make your reservations, click the button below or contact Susan Decker, ACA Director of Conferences at 434-989-5938 or susan@acainfo.org.

Individuals will guarantee reservations with a credit card or deposit equal to the first night’s room and tax.

Reserve Now

2025 Sponsors and Exhibitors

Compounding Clarity: Decoding USP Standards in Pharmacy Practice Bundle

Taisha Cunningham2024-11-05T15:23:33-06:00July 27th, 2023|Categories: compounding, Continuing Education, USP 795, USP 797, Veterinary Compounding|Tags: education, news, pharmacist, Pharmacy Technician, student pharmacist, veterinary|

The Compounding Clarity: Decoding USP Standards in Pharmacy Practice Bundle is accredited for 3.0 contact hours (0.3 CEUs) of continuing education credit for pharmacists and pharmacy technicians.

Click Here to Register

Included Webinars:

GFI #256: How it affects compounding for veterinary patients – 2023 / 0.5 CE
This webinar will help veterinary compounders understand the requirements of GFI-256 and why such a document is necessary in the current federal landscape. Pharmacists and technicians will learn when FDA intends to use enforcement discretion regarding the compounding of animal drugs using bulk drug substances and how to comply with these requirements. They will also learn how they can nominate drugs to the list for compounding office stock drugs used for nonfood-producing animals.

Understanding the revision to USP <795> Pharmaceutical Compounding – Nonsterile Preparations – 2023 / 0.5 CE
This webinar will help pharmacists and technicians understand and prepare for changes to USP <795> Pharmaceutical Compounding – Nonsterile Preparations that will go into effect on November 1, 2023. The webinar will include differentiating dosage forms that may be compounded as nonsterile preparations and how to assign beyond-use dates as well as reviewing changes to facility, personnel, and documentation requirements.

Preparing for change: Key aspects of revised USP <797> Pharmaceutical Compounding – Sterile Preparations / 1 CE
This webinar will help pharmacists and technicians understand and prepare for changes to USP <797> Pharmaceutical Compounding – Sterile Preparations that will take effect on November 1, 2023. The webinar will include an overview of requirements including the transition to Category 1, Category 2, and Category 3 compounded sterile preparations and what each of these entails. Topics covered include requirements for facility and equipment, environmental monitoring, personnel training, and competency, documentation, and quality management.

Interpreting and Applying USP Compounded Preparation Monographs in Pharmacy Practice: Recipes for Quality / 1 CE
Since 1820, USP has published Compounded Preparation Monographs (CPMs) with the goal of standardizing quality-assured formulas for the most commonly used compounded preparations for humans and animals. While most pharmacy professionals are aware of these monographs, many do not understand the significance and utility of each of the sections of a monograph. Join this webinar to learn where to find and how to interpret the meaning and intent of these unique “recipes” and how to apply them to your veterinary pharmacy practice.

Thanks to our partnership with the American College of Veterinary Pharmacy

Our Speakers:

Gigi Davidson, RPh, DICVP, FACVP, FSVHP is the former Director of Clinical Pharmacy at the NC State University College of Veterinary Medicine where she practiced veterinary pharmacy for 35 years. Ms. Davidson received a pharmacy degree from UNC-Chapel Hill in 1983 and earned Diplomate status in the International College of Veterinary Pharmacy in 2001. She was inducted into the Phi Zeta Honor Society in 2006 as an honorary member for distinguished advancement of veterinary science. Gigi is a past President of the Society of Veterinary Hospital Pharmacists and of the American College of Veterinary Pharmacists. Ms. Davidson is the ACVP delegate to the American Pharmacists Association House of Delegates. Ms. Davidson was the Chair of the United States Pharmacopeia Compounding Expert Committee from 2010-2020 and continues to serve as a member. Gigi is the recipient of USP’s Beal Award when in 2015 she became the first female and first veterinary recipient of that award. She has many publications in peer-reviewed scientific journals, and her primary area of research interest is the stability, safety, and efficacy of compounded therapies in non-human species. Her research interests in retirement include drug disposition in honey bees and the pharmacological action of plant pollens and nectars on honey bee colonies.

Brenda Jensen CPhT, CNMT, MBA owns Compounding Consultants, LLC in Sioux Falls, SD. She has helped hundreds of compounding facilities across the country improve compounding quality and safety. Brenda is currently president-elect of the American College of Veterinary Pharmacists, serves on the Board of Directors for the American College of Apothecaries Research and Education Foundation, is a peer reviewer for Pharmacy Technician’s Letter, is a member of the APhA House of Delegates, and also teaches compounding courses for the American College of Apothecaries. She was previously the coordinator for the APhA Compounding Special Interest Group and served on the Board of Directors for the International Academy of Compounding Pharmacists and the Pharmacy Compounding Foundation. Brenda began volunteering for USP in 2013 and is currently Chair of the 2020–2025 Compounding Expert Committee.

INDUSTRY UPDATE: USP 795 & Quality Nonsterile Compounds Webinar

Terry Bondurant2022-09-27T15:25:52-05:00September 13th, 2022|Categories: Pharmacist Training, Pharmacy Technician, USP 795|Tags: education, pharmacist|

USP has proposed revisions to chapter <795> which creates minimum standards for compounding of nonsterile dosage forms for both human and animal patients. Attendees will learn about the changes from the current version of USP <795>, highlight key themes in the proposed changes, and prepare themselves to meet or exceed these new standards. In addition, attendees will learn how some the concepts coincide with the FDA’s Insanitary Conditions Guidance document and the role this currently plays in pharmacy practice.

Tuesday, October 11, 2022
12 Noon Eastern / 11:00 am Central / 10:00 am Mountain / 9:00 am Pacific

ACA & ACVP Members: FREE
Non-Members: $20

Learning Objectives:

Define the changes in the proposed USP <795> compared to the current USP <795>
Illustrate the role that personnel and appropriate facilities play in limiting potential contamination of nonsterile compounds.
Analyze the key themes of the proposed USP <795> and how they coincide with the FDA’s Insanitary Conditions Guidance
Plan to implement any changes needed for compliance and quality of nonsterile compounds.

This webinar does not offer CE.

Register below. After you register, you will be directed to Zoom to complete your sign up and receive your Zoom webinar links via email.

Loading…

Matt Martin, PharmD, BCSCP, joined the PCCA Clinical Services team in September 2014 and now serves as Director of Clinical Services. He graduated from Morehead State University with a BS in Chemistry in 2002 and received his PharmD from the University of Kentucky College of Pharmacy in 2006. In 2020, Matt became board certified in Compounded Sterile Preparations through the Board of Pharmacy Specialties. Prior to joining the PCCA team, Matt worked in compounding pharmacy for more than eight years and has experience with both sterile and non-sterile preparations.

ACA’s Response to the Update on USP Compounding Standards

Dana2019-09-25T14:45:00-05:00September 25th, 2019|Categories: News Release, USP 795, USP 797|

On September 23, 2019, ACA received notification that due to ongoing appeals, implementation of proposed changes to USP Chapters 795 and 797 will not occur on December 1, 2019. This is good news for compounding pharmacy: the scope of the revisions to USP Chapters 795 and 797 – and the impact that the current revisions as written would have on maintaining patients’ access to compounded medications and on the preservation of local, independent community pharmacies’ ability to continue to compound—were too great.

ACA is committed to providing compounding training that reflects the USP Chapter Standards. We are in the process of updating the curricula for our 2020 live and online courses to reflect the proposed changes as they are currently written. Once USP makes a decision to deny or remand the ongoing appeals to Chapters 795 and 797, and communicates a new implementation schedule, we will adjust our revisions and training updates accordingly on our website.

If you have any questions about ACA compounding training or the inclusion of USP Chapter Standards in our curricula, please contact us at training@acainfo.org. Click here to read the notice from USP.

Sincerely,

Susan Bartlemay, RPh, FACA, FAPhA
Executive Director | CEO
American College of Apothecaries

Your registration includes:

Speakers Include:

Reservations

2025 Sponsors and Exhibitors

navigation

affiliates

connect

refer a colleague